Foam is widely considered to be the future delivery form for dermatological drugs. Rubbing creams or ointments into the skin is inefficient, time-consuming, and leaves the skin feeling greasy - future skin-care patients are likely to receive their treatments in a foam that can easily be spread across large areas of the body with minimum fuss and maximum absorption.

Permethrin 1% in Foamix's Emollient Foam base.

The proprietary Foamix Permethrin 1% foam is a unique, clinically tested product for the treatment of head lice (pediculosis), which is very common and is distributed worldwide. Preschool and elementary-age children, 3 to 10 years of age are infected most often.

The product was designed to provide maximum convenience to the parents, who do not have to deal with lotions that drip or shampoos that irritate the eyes. Foamix Permethrin 1% is ideal for application to the scalp and pubic area.

Clinical trials have demonstrated a favorable safety profile (no side effects) and more than 95% efficacy in killing lice. Notably, the trials were performed in populations that are known to possess pediculocide resistence, and still, the performance was extremely high.

Foamix is concurrently developing a 5% permethrin foam as a prescription drug for lice and scabies.

• Permethrin 1% and 5% in Foamix Emollient Foam base.
• Permethrin 1% - Clinically proven efficacy: more than 96% success in killing lice and eggs..
• Ideal for application to the scalp and pubic area.
• Most suitable to treat head lice (1%), pubic lice and scabies (5%).